Vycellix Announces Formation of Scientific Advisory BoardAllbiopro2019-06-26T09:12:37+09:006월 26th, 2019|
Aldeyra’s Reproxalap Falls Short in Anterior Uveitis TrialAllbiopro2019-06-26T09:12:09+09:006월 26th, 2019|
Prescription Medication Costs Shaping Up to Become Central Issue in ElectionAllbiopro2019-06-26T09:11:41+09:006월 26th, 2019|
Frontier Medicines Closes $67 Million Series A, Will Focus on ChemoproteomicsAllbiopro2019-06-26T09:11:13+09:006월 26th, 2019|
Almirall Exercises Licensing Option for Dermira’s Atopic Dermatitis DrugAllbiopro2019-06-26T09:10:44+09:006월 26th, 2019|
FDA Rejects Acer Therapeutics’ Rare Disease Drug, Calls for New TrialAllbiopro2019-06-26T09:10:16+09:006월 26th, 2019|
City of Hope Invests $1 Billion-Plus in Comprehensive Cancer CenterAllbiopro2019-06-26T09:09:48+09:006월 26th, 2019|
Conatus to Cut Staff by 40%, Consider Sale in Light of Recent FailuresAllbiopro2019-06-26T09:08:52+09:006월 26th, 2019|
New Insights on Why Checkpoint Inhibitors Don’t Always WorkAllbiopro2019-06-26T09:08:23+09:006월 26th, 2019|
AbbVie Makes ‘Transformational’ Move with $63 Billion Acquisition of AllerganAllbiopro2019-06-26T09:07:56+09:006월 26th, 2019|
Novartis sells Colorado site to maker of CBD productsAllbiopro2019-06-26T09:07:28+09:006월 26th, 2019|
Pharma’s got its chief digital officers. Now let’s see results: Sanofi execAllbiopro2019-06-26T09:07:00+09:006월 26th, 2019|
Horizon bulks up sales force ahead of $750M inflammatory eye drug launchAllbiopro2019-06-26T09:06:31+09:006월 26th, 2019|
Novartis’ Gilenya staves off generic challengers—for now—after federal injunctionAllbiopro2019-06-26T09:05:36+09:006월 26th, 2019|
After being snapped up by Alexion, Syntimmune’s CEO joins MorphoSysAllbiopro2019-06-26T09:05:08+09:006월 26th, 2019|
Verona hires ex-GSK researchers for late-phase push in COPDAllbiopro2019-06-26T09:04:40+09:006월 26th, 2019|
